Through the identification of a list of potentially repurposable FDA-approved therapeutics that target steroid-responsive gene targets, we present a list of potential novel therapeutics for further investigation to treat steroid-responsive inner ear diseases, including SSNHL, MD, and AIED. This evidence concerns the gene CACNA1F and inner ear disorder.